Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Joseph Lee, Youichi Naoe, Uikyu Bang, Yu Nakagama, Akatsuki Saito, Yasutoshi Kido & Akitsu Hotta. (2024) Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera. Virology 595, pages 110067.
Crossref
Crossref
Xiao-Lin Jiang, Xue-Dong Song, Chao Shi, Guo-Jian Yang, Xue-Jun Wang, Yu-Wei Zhang, Jie Wu, Lian-Xiang Zhao, Ming-Zhu Zhang, Ming-Ming Wang, Rui-Rui Chen, Xue-Juan He, Er-Hei Dai, Hui-Xia Gao, Yuan Shen, Gang Dong, Yu-Ling Wang & Mai-Juan Ma. (2024) Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection. Cell Reports 43:7, pages 114387.
Crossref
Crossref
Yucai Liang, Weiling Xiao, Yuan Peng, Shengshuo Zhang, Jinhua Dong, Jun Zhao, Yuhui Wang, Mengtao Zhang, Zhijun Liu & Bowen Yu. (2024) Development of nanoparticle vaccines utilizing designed Fc-binding homo-oligomers and RBD-Fc of SARS-CoV-2. Antiviral Research 227, pages 105917.
Crossref
Crossref
Veronica Ferrucci, Marco Miceli, Chiara Pagliuca, Orazio Bianco, Luigi Castaldo, Luana Izzo, Marica Cozzolino, Carla Zannella, Franca Oglio, Antonio Polcaro, Antonio Randazzo, Roberta Colicchio, Massimiliano Galdiero, Roberto Berni Canani, Paola Salvatore & Massimo Zollo. (2024) Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties. Journal of Translational Medicine 22:1.
Crossref
Crossref
Song Xue, Yuru Han, Fan Wu & Qiao Wang. (2024) Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. Protein & Cell 15:6, pages 403-418.
Crossref
Crossref
Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Sian Xiao, Peng Tao & Gennady Verkhivker. (2024) AlphaFold2 Predictions of Conformational Ensembles and Atomistic Simulations of the SARS-CoV-2 Spike XBB Lineages Reveal Epistatic Couplings between Convergent Mutational Hotspots that Control ACE2 Affinity. The Journal of Physical Chemistry B 128:19, pages 4696-4715.
Crossref
Crossref
Pei Li, Yajie Liu, Julia N. Faraone, Cheng Chih Hsu, Michelle Chamblee, Yi-Min Zheng, Claire Carlin, Joseph S. Bednash, Jeffrey C. Horowitz, Rama K. Mallampalli, Linda J. Saif, Eugene M. Oltz, Daniel Jones, Jianrong Li, Richard J. Gumina & Shan-Lu Liu. (2024) Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion. mBio 15:5.
Crossref
Crossref
Qingwen He, Yaling An, Xuemei Zhou, Haitang Xie, Lifeng Tao, Dedong Li, Anqi Zheng, Linjie Li, Zepeng Xu, Shufan Yu, Ruyue Wang, Hua Hu, Kefang Liu, Qihui Wang, Lianpan Dai, Kun Xu & George F. Gao. (2024) Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies. Med 5:5, pages 401-413.e4.
Crossref
Crossref
Xiaojuan Zhang, Stephanie Joy-Ann Lam, Jonathan Daniel Ip, Carol Ho-Yan Fong, Allen Wing-Ho Chu, Wan-Mui Chan, Yoyo Suet-Yiu Lai, Hoi-Wah Tsoi, Brian Pui-Chun Chan, Lin-Lei Chen, Xinjie Meng, Shuofeng Yuan, Hanjun Zhao, Vincent Chi-Chung Cheng, Jacqueline Kwan Yuk Yuen, Kwok-Yung Yuen, Jie Zhou & Kelvin Kai-Wang To. (2024) Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid. iScience 27:5, pages 109706.
Crossref
Crossref
Weiqi Hong, Hong Lei, Dandan Peng, Yuhe Huang, Cai He, Jingyun Yang, Yanan Zhou, Jian Liu, Xiangyu Pan, Haiying Que, Aqu Alu, Li Chen, Jiayuan Ai, Furong Qin, Binhan Wang, Danyi Ao, Zhen Zeng, Ying Hao, Yu Zhang, Xiya Huang, Chunjun Ye, MinYang Fu, Xuemei He, Zhenfei Bi, Xuejiao Han, Min Luo, Hongbo Hu, Wei Cheng, Haohao Dong, Jian Lei, Lu Chen, Xikun Zhou, Wei Wang, Guangwen Lu, Guobo Shen, Li Yang, Jinliang Yang, Jiong Li, Zhenling Wang, Xiangrong Song, Qiangming Sun, Shuaiyao Lu, Youchun Wang, Ping Cheng & Xiawei Wei. (2024) A chimeric adenovirus‐vectored vaccine based on Beta spike and Delta RBD confers a broad‐spectrum neutralization against Omicron‐included SARS‐CoV‐2 variants. MedComm 5:5.
Crossref
Crossref
Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta & Gennady Verkhivker. (2024) Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape. International Journal of Molecular Sciences 25:8, pages 4281.
Crossref
Crossref
Samuel M.S. Cheng, Chris K.P. Mok, John K.C. Li, Ken K.P. Chan, Kristine S. Luk, Ben H.W. Lee, Haogao Gu, Karl C.K. Chan, Leo C.H. Tsang, Karen Y.S. Yiu, Ken K.C. Ling, Yun Sang Tang, Leo L.H. Luk, Jennifer K.M. Yu, Andrew Pekosz, Richard J. Webby, Benjamin J. Cowling, David S.C. Hui & Malik Peiris. (2024) Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination. Virology Journal 21:1.
Crossref
Crossref
Qianyun Liu, Meihua Jin, Fanghua Mei, Hui Fan, Mengxue Gu, Yuzhen Zhang, Shengnan Qian, Xue Tan, Lei Ji, Zhen Zhang, Guozhong Chen, Huan Yan, Yu Chen, Ke Lan, Qing Geng, Kun Cai & Li Zhou. (2024) A long-term cohort study: the immune evasion and decreasing neutralization dominated the SARS-CoV-2 breakthrough infection. Frontiers in Cellular and Infection Microbiology 14.
Crossref
Crossref
Delphine Planas, Isabelle Staropoli, Vincent Michel, Frederic Lemoine, Flora Donati, Matthieu Prot, Francoise Porrot, Florence Guivel-Benhassine, Banujaa Jeyarajah, Angela Brisebarre, Océane Dehan, Léa Avon, William Henry Bolland, Mathieu Hubert, Julian Buchrieser, Thibault Vanhoucke, Pierre Rosenbaum, David Veyer, Hélène Péré, Bruno Lina, Sophie Trouillet-Assant, Laurent Hocqueloux, Thierry Prazuck, Etienne Simon-Loriere & Olivier Schwartz. (2024) Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion. Nature Communications 15:1.
Crossref
Crossref
Hang Su, Jun Zhang, Zhenfei Yi, Sajid Khan, Mian Peng, Liang Ye, Alan Bao, Han Zhang, Guangli Suo, Qian Li, Housheng Zheng, Dandan Wu, Thomas J. Kipps, Lanfeng Wang, Zhenghong Lin & Suping Zhang. (2024) A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif. hLife 2:3, pages 126-140.
Crossref
Crossref
Zhaohui Cai, Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Benjamin Haner, Mi Wang, Bahar Osman, Dominic Dent, Sheau-Line Feng, Zach Longacre, Greg Glenn & Joyce S. Plested. (2024) A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2–Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms 12:3, pages 501.
Crossref
Crossref
Jihai Tang, Qinghua Xu, Chaoyin Zhu, Kun Xuan, Tao Li, Qingru Li, Xingya Pang, Zhenqiu Zha, Jinwei Li, Liyang Qiao, Haiyang Xu, Gang Wu, Yan Tian, Jun Han, Cuige Gao, Jiang Yi, Gui Qian, Xuxin Tian & Liangzhi Xie. (2024) Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial. Vaccines 12:2, pages 175.
Crossref
Crossref
Panke Qu, Kai Xu, Julia N. Faraone, Negin Goodarzi, Yi-Min Zheng, Claire Carlin, Joseph S. Bednash, Jeffrey C. Horowitz, Rama K. Mallampalli, Linda J. Saif, Eugene M. Oltz, Daniel Jones, Richard J. Gumina & Shan-Lu Liu. (2024) Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell 187:3, pages 585-595.e6.
Crossref
Crossref
Rafael Rahal Guaragna Machado, Érika Donizetti Candido, Andressa Simoes Aguiar, Vanessa Nascimento Chalup, Patricia Romão Sanches, Erick Gustavo Dorlass, Deyvid Emanuel Amgarten, João Renato Rebello Pinho, Edison Luiz Durigon & Danielle Bruna Leal Oliveira. (2024) Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster. Vaccines 12:2, pages 144.
Crossref
Crossref
Xiaoyu Zhao & Feng Gao. (2024) Novel Omicron Variants Enhance Anchored Recognition of TMEM106B: A New Pathway for SARS-CoV-2 Cellular Invasion. The Journal of Physical Chemistry Letters 15:3, pages 671-680.
Crossref
Crossref
Stephen Varvel, Marzena Galdzicka, Stephanie Nystrom, Hong Liu, Ge Chen, Izabela Ragan & Shahrokh Shabahang. (2024) An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5. Frontiers in Immunology 15.
Crossref
Crossref
Jorge Quarleri, M. Victoria Delpino & Veronica Galvan. (2024) Anticipating the future of the COVID-19 pandemic: insights into the emergence of SARS-CoV-2 variant JN.1 and its projected impact on older adults. GeroScience 46:3, pages 2879-2883.
Crossref
Crossref
Fanchong Jian, Leilei Feng, Sijie Yang, Yuanling Yu, Lei Wang, Weiliang Song, Ayijiang Yisimayi, Xiaosu Chen, Yanli Xu, Peng Wang, Lingling Yu, Jing Wang, Lu Liu, Xiao Niu, Jing Wang, Tianhe Xiao, Ran An, Yao Wang, Qingqing Gu, Fei Shao, Ronghua Jin, Zhongyang Shen, Youchun Wang, Xiangxi Wang & Yunlong Cao. (2023) Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding. PLOS Pathogens 19:12, pages e1011868.
Crossref
Crossref
Ling Li, Xixian Chen, Zuowei Wang, Yunjian Li, Chen Wang, Liwei Jiang & Teng Zuo. (2023) Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages. PLOS Pathogens 19:12, pages e1011856.
Crossref
Crossref
Julia N. Faraone & Shan-Lu Liu. (2023) Immune imprinting as a barrier to effective COVID-19 vaccines. Cell Reports Medicine 4:11, pages 101291.
Crossref
Crossref